Structural properties for selective and efficient l-type amino acid transporter 1 (LAT1) mediated cellular uptake.

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• l-Type amino acid transporter 1 (LAT1) facilitates transport of large neutral amino acids and drugs across cell membranes.
• LAT1 is highly expressed in the blood-brain barrier and various cancer cells, making it a significant drug target.
• Structural determinants of LAT1 binding and transport remain incompletely understood.

Purpose of the Study:

• To investigate the structural features influencing binding and transport by human LAT1.
• To evaluate the cellular uptake of compounds utilizing LAT1 in breast adenocarcinoma cells (MCF-7).
• To identify design principles for LAT1-targeting agents for cancer imaging and therapeutics.

Main Methods:

• Assessed binding of various compounds to human LAT1.
• Measured cellular translocation and accumulation of compounds in MCF-7 cells.
• Compared the effects of different conjugation positions (meta vs. para) and structural moieties on LAT1 interaction.

Main Results:

• Meta-conjugation of l-phenylalanine enhanced LAT1 binding compared to para-conjugation or aliphatic moieties.
• Large, rigid, aromatic meta-substituted l-phenylalanine derivatives demonstrated selective and efficient LAT1-mediated cellular uptake.
• Cellular accumulation studies are crucial for assessing transport efficiency and selectivity, complementing binding data.

Conclusions:

• Specific structural features, particularly meta-substitution, can optimize LAT1 binding and transport.
• The study provides a methodological framework and structural insights for designing novel LAT1-utilizing compounds.
• These findings support the development of advanced cancer imaging agents and targeted drug delivery systems.